DETECTING COGNITIVE DISORDERS USING THE MUISTIKKO WEB-BASED COGNITIVE TEST BATTERY: VALIDATION IN THREE COHORTS Teemu Paajanen, Shadi Mahdiani, Marie.

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

Sleep disruption changes across the disease trajectory: Pilot findings from the healthy patterns sleep study Nancy A. Hodgson, Albert J. Safi Alzheimer's.

Capillary dysfunction in Alzheimer's disease

DIAGNOSTIC ACCURACY AND CONFIDENCE IN THE CLINICAL DETECTION OF COGNITIVE IMPAIRMENT IN EARLY-STAGE PARKINSON’S DISEASE Kathryn A. Wyman-Chick, Phillip.

Vladimir S. Fonov, Mahsa Dadar, Xiao Yiming, D. Louis Collins

Relationship between Microstructural Degeneration of the Corpus Callosum, White Matter Hyperintensities, and Motor Function in Cognitively Intact Elderly

Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer’s disease study Wesley.

Hilkka Liedes, Jyrki Lötjönen, Gerald P. Novak, Mark Forrest Gordon

Different pathways to Alzheimer’s disease

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

A SYSTEMATIC REVIEW AND META-ANALYSIS COMPARING QUALITY-OF-LIFE RATINGS FROM FAMILY AND PAID CAREGIVERS OF PEOPLE WITH DEMENTIA RESIDING IN CARE HOMES

Flora H. Duits, Niels D. Prins, Afina W. Lemstra, Yolande A. L

Cerebrospinal fluid biomarkers for Alzheimer's disease are associated with neuropathology in cortical brain biopsy Toni Seppälä, Ossi Nerg, Anne Koivisto,

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

INCREASED CSF LEVELS OF BIOMARKERS FOR NEURODEGENERATION IN FTLD-GRN MUTATION CARRIERS Joery Goossens, Sara Van Mossevelde, Tobi Van den Bossche, Anne.

The differential diagnosis of amnestic mild cognitive impairment and Alzheimer's disease dementia by hippocampal volume measurement with MR in a chinese.

Localization of Hippocampal atrophy in Alzheimer's disease

Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints Argonde C. van Harten, Pieter Jelle Visser,

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia Anja Hviid Simonsen, Sanna-Kaisa Herukka, Niels Andreasen, Ines Baldeiras,

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

A NOVEL NEUROIMAGING APPROACH TO CAPTURE COGNITIVE RESERVE

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Christine Bredfeldt, Kristen Rice, Lisa Alecxih

KETOGENIC DIET EFFECTS ON BRAIN KETONE METABOLISM AND ALZHEIMER'S DISEASE CSF BIOMARKERS Suzanne Craft, Bryan J. Neth, Akiva Mintz, Kiran Sai, Nora Shively,

The effect of using a conditional discrimination procedure to teach name-face relation to a person diagnosed with dementia Hanna S. Steingrimsdottir,

Application of Resource Utilization in Dementia (RUD) instrument in a global setting Anders Wimo, Anders Gustavsson, Linus Jönsson, Bengt Winblad, Ming-Ann.

Alzheimer’s disease core biomarkers and prediction of dementia in MCI: The effect of age at onset Anna Caroli, Samantha Galluzzi, Clarissa Ferrari, Annapaola.

DATA-DRIVEN TAU-PET COVARIANCE NETWORKS ENHANCE PREDICTION OF RETROSPECTIVE COGNITIVE CHANGE IN ALZHEIMER’S DISEASE Jacob W. Vogel, Niklas Mattsson,

LATENT-FACTOR STRUCTURE OF THE DELCODE STUDY NEUROPSYCHOLOGICAL TEST BATTERY Steffen Wolfsgruber, Luca Kleineidam, Jannis Guski, Oliver Peters, Katharina.

HYPERGLYCEMIA: PREDISPOSITION FOR MICROEMBOLI, STROKE, AND WHITE MATTER CHANGES Leila Parand, Saif Bushnaq, Yue Wang, Lenora Mathes, Dinesh Jillella,

Marjolein Bulk, Linda van der Graaf, Walid M

Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment Sanna-Kaisa Herukka,

Colin Groot, Chris W. J. van der Weijden, Wiesje M

Thinner temporal and parietal cortex is related to incident clinical progression to dementia in patients with subjective cognitive decline Sander C.J.

Japanese brain bank network for neuroscience research

A TRANSCULTURAL COGNITIVE MARKER OF ALZHEIMER'S DISEASE

Community environment and incident dementia: Results from the three-city study Claudine Berr, Laure Anne Gutierrez, Sylvaine Artero, Catherine Helmer,

Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study Kumar B. Rajan, Jennifer Weuve,

Application of Resource Utilization in Dementia (RUD) instrument in a global setting Anders Wimo, Anders Gustavsson, Linus Jönsson, Bengt Winblad, Ming-Ann.

Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics:

Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study Kumar B. Rajan, Jennifer Weuve,

American Journal of Kidney Diseases

LIFESPAN OF ONE FOCUSED ULTRASOUND MEDIATED BLOOD-BRAIN BARRIER TREATMENT IN A MOUSE MODEL OF ALZHEIMER'S DISEASE Charissa Poon, Kullervo Hynynen Alzheimer's.

Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective Matthew Baumgart, Heather M. Snyder,

Comparison of visual and quantitative florbetapir-PET reads in subjects with early Alzheimer's disease for assessing amyloid burden Bradley Wyman, Yahong.

Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer’s Disease Nina Kokkonen, Sanna-Kaisa.

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

The incremental diagnostic value of 18F-florbetapir imaging in naturalistic patients with cognitive impairment: The India-FBP study Marina Boccardi,

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Linus Jönsson, Pei-Jung Lin, Ara S. Khachaturian

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Added value of 11C-PiB-PET imaging in the diagnosis of Alzheimer's disease Kristian Frederiksen, Anne-Mette Hejl, Ian Law, Steen Hasselbalch, Gunhild.

Mark D. Meadowcroft, Douglas G. Peters, Carson J

COGNITIVE COMPLAINTS IN OLDER ADULTS AT RISK FOR ALZHEIMER’S DISEASE ARE ASSOCIATED WITH ALTERED RESTING STATE NETWORKS Joey A. Contreras, Joaquín Goñi,

Distinct [18F]AV1451 retention patterns in clinical variants of Alzheimer’s disease Rik Ossenkoppele, Daniel Schonhaut, Suzanne Baker, Andreas Lazaris,

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

GREY MATTER CONNECTIVITY IS ASSOCIATED WITH CLINICAL PROGRESSION IN NON-DEMENTED, AMYLOID POSITIVE PATIENTS Betty M. Tijms, Mara ten Kate, Sander C.J.

Alzheimer's Association towards Guidelines for Dementia Care Practice: Recommendations with emphasis on high-quality, person-centered care in long-term.

Tharick A. Pascoal, Sulantha S

Different pathways to Alzheimer’s disease

Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics:

INTRINSIC CONNECTIVITY NETWORKS IN POSTERIOR CORTICAL ATROPHY: A ROLE FOR THE PULVINAR? Carolyn A. Fredericks, Jesse Brown, Jersey Deng, Rik Ossenkoppele,

Automated detection of beta-amyloid–related cortical and subcortical signal changes in a transgenic model of Alzheimer's disease using high-field MRI

Extracting white matter hyperintensities in Alzheimer's disease risk and aging studies using supervised segmentation methods Vamsi Ithapu, Vikas Singh,

BRAIN AMYLOIDOSIS AND COGNITIVE DECLINE IN MCI: 12-MONTH FOLLOW-UP

Michael Navitsky, Abhinay D. Joshi, Michael D. Devous, Michael J

Presentation transcript:

DETECTING COGNITIVE DISORDERS USING THE MUISTIKKO WEB-BASED COGNITIVE TEST BATTERY: VALIDATION IN THREE COHORTS Teemu Paajanen, Shadi Mahdiani, Marie Bruun, Marta Baroni, Hanneke F.M. Rhodius- Meester, Afina W. Lemstra, Sanna-Kaisa Herukka, Maria Pikkarainen, Tuomo Hänninen, Tiia Ngandu, Miia Kivipelto, Mark van Gils, Steen Gregers Hasselbalch, Patrizia Mecocci, Wiesje M. van der Flier, Anne Remes, Hilkka Soininen, Jyrki Lotjonen Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 13, Issue 7, Pages P234-P235 (July 2017) DOI: 10.1016/j.jalz.2017.06.076 Copyright © 2017 Terms and Conditions

Figure 1 The distribution of GCS and MGCS shown for different diagnostic groups. GCS and MGCS is a value ranging from 0=completely normal to 1=completely abnormal. The dementia group (n=50) includes Alzheimer disease (AD) patients (n=31) and 19 subjects with other dementia diagnosis. Alzheimer's & Dementia: The Journal of the Alzheimer's Association 2017 13, P234-P235DOI: (10.1016/j.jalz.2017.06.076) Copyright © 2017 Terms and Conditions